Stepien Karolina M, Stewart Fiona J, Hendriksz Chris J
Adult Inherited Metabolic Disorders, The Mark Holland Metabolic Unit, Salford Royal Foundation NHS Trust, Ladywell NW2- 2nd Floor Room 112, Salford, Manchester, M6 8HD, United Kingdom.
N.I. Regional Genetics Service, Level A, Belfast City Hospital, Lisburn Rd, Belfast BT9 7AB, United Kingdom.
Mol Genet Metab Rep. 2017 May 18;12:35-40. doi: 10.1016/j.ymgmr.2017.05.006. eCollection 2017 Sep.
Mucopolysaccharidoses (MPS) are a group of rare inherited disorders characterized by abnormal accumulation of glycosaminoglycans (GAGs) within the myocytes and coronary arteries. Little is known about hyperlipidaemia as a potential cardiovascular risk factor in these patients. Baseline cholesterol data in adults are scarce. Therefore, the aim of this study was to analyse factors affecting lipid profile in different types of MPSs to determine if abnormalities in lipid profile contribute to the overall risk of cardiovascular disease.
Adult patients (above the age of 16) with MPS type I, II, III, IV and VI attending clinics in two Inherited Metabolic Disorders centres were included. Their lipid profile, lipoprotein (a), HbA1c, Glucose Tolerance Test (GTT), BMI and treatment type were extracted. Analysis included descriptive statistics and Student -test.
Eighty two patients with five MPS types (I, II, III, IV and VI) were included in the study; 29 were females (35%) and 53 were males (65%). BMI above 25 kg/m in all MPS types indicated that some patients were overweight for their height. Only one patient post-HSCT had diabetes. In 3 cases insulin was analysed during GTT and showed no insulin resistance despite raised BMI. Mean total cholesterol and LDL-cholesterol were below 5 mmol/L and 3 mmol/L, respectively, in five individual MPS types. Lipoprotein (a) was available for 6 MPS IV patients and was not significantly raised.
MPS disorders are not associated with significant hypercholesterolaemia or diabetes mellitus despite increased BMI. Total cholesterol and LDL-cholesterol were within the targets for primary prevention for non-MPS population. Lipoprotein (a) is not a useful marker of cardiovascular disease in a small group of adult MPS IV patients irrespectively of treatment option. Whether long-term cardiovascular risk is dependent on lipid profile, diabetes, obesity or GAGs deposition within the organ system remains unanswered.
黏多糖贮积症(MPS)是一组罕见的遗传性疾病,其特征是糖胺聚糖(GAGs)在心肌细胞和冠状动脉内异常蓄积。关于高脂血症作为这些患者潜在心血管危险因素的情况知之甚少。成人的基线胆固醇数据稀缺。因此,本研究的目的是分析影响不同类型MPS患者血脂谱的因素,以确定血脂谱异常是否会增加心血管疾病的总体风险。
纳入在两个遗传代谢疾病中心就诊的16岁以上的I型、II型、III型、IV型和VI型MPS成年患者。提取他们的血脂谱、脂蛋白(a)、糖化血红蛋白(HbA1c)、葡萄糖耐量试验(GTT)、体重指数(BMI)和治疗类型。分析包括描述性统计和t检验。
本研究纳入了82例患有五种MPS类型(I型、II型、III型、IV型和VI型)的患者;29例为女性(35%),53例为男性(65%)。所有MPS类型中BMI高于25kg/m²表明一些患者按身高计算超重。仅1例造血干细胞移植后患者患有糖尿病。3例患者在GTT期间进行了胰岛素分析,尽管BMI升高,但未显示胰岛素抵抗。五种MPS类型中,平均总胆固醇和低密度脂蛋白胆固醇分别低于5mmol/L和3mmol/L。6例IV型MPS患者检测了脂蛋白(a),其水平未显著升高。
尽管BMI升高,但MPS疾病与显著的高胆固醇血症或糖尿病无关。总胆固醇和低密度脂蛋白胆固醇处于非MPS人群一级预防的目标范围内。在一小部分成年IV型MPS患者中,无论治疗方案如何,脂蛋白(a)都不是心血管疾病的有用标志物。长期心血管风险是否取决于血脂谱、糖尿病、肥胖或器官系统内的GAGs沉积仍未得到解答。